Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
Niemann-Pick type C (NPC) disease is a neurodegenerative lysosomal storage disease caused by mutations in either the NPC1 or NPC2 gene. NPC is characterised by storage of multiple lipids in the late endosomal/lysosomal compartment, resulting in cellular and organ system dysfunction. The underlying m...
Main Authors: | Platt, F, Nicoli, E, Al Eisa, N, Cluzeau, C, Wassif, C, Gray, J, Burket, K, Smith, D, Morris, L, Cologna, S, Peer, C, Sissung, T, Uscatu, C, Figg, W, Pavan, W, Vite, C, Porter, F |
---|---|
Format: | Journal article |
Published: |
Public Library of Science
2016
|
Similar Items
-
Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
by: Platt, F, et al.
Published: (2016) -
Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
by: Nicoli, E, et al.
Published: (2016) -
NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.
by: Probert, F, et al.
Published: (2017) -
Case Report: Ursodeoxycholic acid treatment in Niemann-Pick disease type C; clinical experience in four cases
by: Evans, W, et al.
Published: (2017) -
Evaluation of new therapies in Niemann-Pick type C disease
by: Al Eisa, N
Published: (2014)